Document is current
Any future updates will be listed below
-
Authors
Smerilli, Gianluca http://orcid.org/0000-0002-3972-4458
Cipolletta, Edoardo http://orcid.org/0000-0002-6881-8197
Sartini, Gianmarco
Moscioni, Erica
Di Cosmo, Mariachiara http://orcid.org/0000-0002-0269-4304
Fiorentino, Maria Chiara http://orcid.org/0000-0002-7397-803X
Moccia, Sara http://orcid.org/0000-0002-4494-8907
Frontoni, Emanuele http://orcid.org/0000-0002-8893-9244
Grassi, Walter
Filippucci, Emilio http://orcid.org/0000-0002-7251-7784
- License Information
-
More Information
Article History
Received: 5 October 2021
Accepted: 21 January 2022
First Online: 8 February 2022
Declarations
:
: The study was conducted in accordance with the Helsinki Declaration and was approved by the local ethics committee (Comitato Etico Regione Marche, number 262). All patients signed informed consent.
: Not applicable.
: E.F. has received speaking fees from Abbvie, BMS, Janssen, Lilly, MSD, Novartis, Roche, Pfizer, and UCB Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer, and UCB Pharma. All other authors declare that they have no competing interests.
